Related Experiment Video
Updated: May 30, 2025

Staining Protocols for Human Pancreatic Islets
Published on: May 23, 2012
Risk Factors and Mechanisms for Diabetes in Pancreatitis
María Graciela Parra Villasmil1, Melena D Bellin2
1Department of Pediatrics, Stead Family Children's Hospital, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA.
Insights
Diabetes mellitus (DM) is a complication of pancreatitis, impacting over 30% of adults with chronic pancreatitis. Understanding its causes and treatments, especially in children, requires further research.
Area of Science:
- Endocrinology
- Gastroenterology
- Metabolic Disorders
Background:
- Diabetes mellitus (DM) is a known complication of acute and chronic pancreatitis.
- Over 30% of adults with chronic pancreatitis develop diabetes.
- Limited data exists on the pathophysiology and management of pancreatitis-associated DM, particularly in pediatric populations.
Purpose of the Study:
- To summarize current knowledge on the pathophysiology of diabetes in pancreatitis.
- To highlight risk factors associated with developing DM in pancreatitis patients.
- To identify gaps in understanding and suggest areas for future research.
Main Methods:
- Literature review of existing studies on pancreatitis and diabetes.
- Analysis of proposed pathophysiological mechanisms.
- Identification of risk factors from available data.
Main Results:
- Proposed mechanisms include insulin deficiency, insulin resistance, decreased pancreatic polypeptide, and potential beta-cell autoimmunity.
- Risk factors identified: hypertriglyceridemia, obesity, necrotizing pancreatitis, exocrine pancreatic insufficiency, and pancreatic calcifications.
- Significant knowledge gaps remain, especially concerning pediatric cases.
Conclusions:
- Pancreatogenic diabetes is a complex condition with multifactorial causes.
- Further research is essential to elucidate the pathophysiology of DM in pancreatitis.
- Defining optimal treatment strategies necessitates a deeper understanding of the disease mechanisms.
Abstract:
Diabetes (DM) can occur as a complication of acute, acute recurrent, or chronic pancreatitis, affecting more than 30% of adults with chronic pancreatitis. Data on the pathophysiology and management are limited, especially in pediatric population. Proposed mechanisms include insulin deficiency, insulin resistance, decreased pancreatic polypeptide, and possible beta-cell autoimmunity (in a small subset). Risk factors for developing diabetes in those with pancreatitis may include hypertriglyceridemia, obesity, necrotizing pancreatitis, exocrine pancreatic insufficiency, and pancreatic calcifications, among others. Further studies are required to understand pathophysiology of pancreatogenic DM, in order to define optimal treatment approaches.
More Related Videos
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Clinical Manifestations and Management
Diabetes: Symptoms, Diagnosis, and Complications
Chronic Pancreatitis II: Collaborative Care
Assessment:

